Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice

Kimberly Schmitt1, Dipu Mohan Kumar1, James Curlin1

  • 1Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Virology
|July 28, 2017
PubMed

Insights

Humanized mice infected with SIVsm showed productive infection and CD4+ T cell decline, mimicking HIV-2 origins. Viral evolution in mice revealed key genetic changes, aiding study of human pathogen development.

Area of Science:

  • Virology
  • Immunology
  • Primate Retroviruses

Background:

  • Human Immunodeficiency Virus type 2 (HIV-2) is believed to have evolved from Simian Immunodeficiency Virus (SIV) found in sooty mangabeys.
  • Understanding the initial transmission and subsequent viral evolution is crucial for modeling HIV-2 origins and pathogenesis.

Purpose of the Study:

  • To model the initial human transmission of SIVsm.
  • To investigate the sequential viral evolution of SIVsm in a humanized mouse model.
  • To evaluate the potential of SIVsm to evolve into a human pathogen similar to HIV-2.

Main Methods:

  • Humanized mice were infected with SIVsm (SIV from sooty mangabeys).
  • Mice were serially passaged for five generations to observe viral adaptation and evolution.
  • Viral loads, CD4+ T cell counts, and genetic sequences (nef, env, rev regions) were analyzed across generations.

Main Results:

  • Productive infection and chronic viremia were observed, accompanied by a gradual decline in CD4+ T cells.
  • Viral loads increased by the 5th generation, leading to a more accelerated CD4+ T cell depletion.
  • Key nonsynonymous amino acid substitutions fixed in viral genes (nef, env, rev) were identified, particularly within the first two generations.

Conclusions:

  • Humanized mice effectively model SIVsm transmission and initial human adaptation.
  • The study demonstrates SIVsm's capacity for sequential evolution in vivo.
  • Findings provide insights into the evolutionary pathway toward HIV-2 lineage.